Sulfasalazine
Cat.No:IS1550 Solarbio
CAS:599-79-1
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Light yellow to orange Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Apoptosis >
SulfasalazineCAS:599-79-1
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Light yellow to orange Solid
Qty:
Size:
CAS | 599-79-1 |
Name | Sulfasalazine |
Molecular Formula | C18H14N4O5S |
Molecular Weight | 398.39 |
Solubility | Soluble in DMSO ≥5mg/mL |
Purity | ≥98% |
Appearance | Light yellow to orange Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 209-974-3 |
MDL | MFCD00057363 |
SMILES | OC(C1=C(O)C=CC(/N=N/C2=CC=C(S(=O)(NC3=NC=CC=C3)=O)C=C2)=C1)=O |
InChIKey | NCEXYHBECQHGNR-UHFFFAOYSA-N |
InChI | InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25) |
PubChem CID | 5339 |
Target Point | NF-κB; Autophagy; Apoptosis; Ferroptosis |
Passage | NF-κB; Autophagy; Apoptosis |
Background | Sulfasalazine is a potent, specific inhibitor of nuclear factor kappa B (NF-κB). Sulfasalazin can induce iron death, apoptosis and autophagy. |
Biological Activity | Sulfasalazine是治疗类风湿关节炎和溃疡性结肠炎的药物。报道显示Sulfasalazine可抑制 NF-κB 的活性。[1-3] |
In Vitro | 用柳氮磺胺吡啶处理SW620结肠细胞抑制TNFα-,LPS-或佛波醇酯诱导的NFκB活化。在微量至毫摩尔浓度下,柳氮磺胺吡啶可抑制NFκB依赖性转录。通过抑制IκBα降解,柳氮磺胺吡啶可以预防TNFα诱导的NFκB核转位[1]。与载体对照相比,单独用5mM柳氮磺吡啶预孵育显着增加所有促炎细胞因子的基础mRNA表达,IL-6 mRNA水平增加80倍[2]。一旦被消化,柳氮磺胺吡啶被结肠细菌切割成磺胺吡啶和5-氨基水杨酸,后者也被报道抑制NF-κB活性[3]。 |
In Vivo | 在低剂量(0.25 mM)下,与未经治疗的对照相比,SAS能够抑制胶质瘤生长超过60%[3]。 |
Cell Experiment | 柳氮磺胺吡啶溶解在培养基中。 SW620细胞在Dulbecco改良的Eagle培养基中生长,补充有10%热灭活的FCS,2mmol /升谷氨酰胺和1%(wt / vol)青霉素/链霉素。用3xIgkBLuc报道构建体转染SW620细胞。 18小时后,在用TNFα,LPS或PMA刺激之前,将细胞与单独的培养基或柳氮磺胺吡啶(0.1,0.2,0.5,1,2,5mM)一起温育。进行荧光素酶测定[1]。 |
Animal Experiment | 小鼠:将柳氮磺胺吡啶溶于0.1M NaOH中,然后用0.1M HCl滴定中和。将U-87MG神经胶质瘤细胞植入SCID小鼠的颅骨中。 7天后,将动物随机分成三组,每组五只动物。一组每天两次接受1mL ip盐水注射,持续3周。两个试验组每天两次在1mL盐水中接受8mg柳氮磺吡啶,持续3周。监测肿瘤生长和动物健康。用4%多聚甲醛灌注后,收集小鼠脑,冲洗,并置于30%蔗糖中[3]。 |
Data Literature Source | [1]. Wahl C, et al. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998 Mar 1; 101 (5) :1163-74. [2]. Sykes L, et al. Sulfasalazine augments a pro-inflammatory response in interleukin-1β-stimulated amniocytes and myocytes. Immunology. 2015 Dec; 146 (4) :630-44. [3]. Chung WJ, et al. Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB. J Neurochem. 2009 Jul; 110 (1) :182-93 |
Unit | Bottle |
Specification | 500mg 10mM*1mL in DMSO 1g |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.